pertain
viral
infect
may
either
increas
decreas
subsequ
risk
asthma
discuss
final
potenti
use
antivir
antiinflammatori
medicin
prevent
treatment
asthma
consid
asthma
diseas
character
chronic
airway
inflamm
heighten
respons
airway
irrit
case
allergen
fig
chronic
inflamm
asthma
pleiotrop
pictur
usual
includ
increas
number
activ
cell
predominantli
secret
helper
h
cytokin
interleukin
pattern
cytokin
secret
togeth
secret
epithelialderiv
chemokin
eotaxin
rant
regul
activ
normal
cell
express
secret
promot
recruit
activ
eosinophil
mast
cell
contribut
chronic
airway
inflamm
hyperrespons
airway
varieti
nonspecif
stimuli
factor
togeth
chronic
structur
chang
airway
increas
product
mucu
goblet
cell
increas
risk
intermitt
episod
acut
obstruct
airflow
small
airway
lung
respons
irrit
tobacco
smoke
air
pollut
allergen
acut
viral
infect
pattern
inflamm
viral
infect
effect
asthma
appear
distinct
associ
allergen
activ
exposur
allergen
caus
airway
eosinophilia
wherea
viral
infect
elicit
neutrophil
respons
furthermor
contrast
allergeninduc
wheez
virusinduc
wheez
ill
respond
incomplet
standard
asthma
therapi
administr
bronchodil
inhal
corticosteroid
observ
highlight
need
understand
better
pathogenesi
virusinduc
wheez
exacerb
asthma
consequ
enabl
develop
new
therapeut
approach
common
ill
studi
determin
effect
viral
infect
develop
asthma
yield
controversi
conflict
result
collect
howev
variabl
studi
result
may
attribut
sever
factor
includ
specif
viral
pathogen
sever
ill
anatom
locat
ill
age
affect
individu
follow
section
relationship
viral
infect
wheez
ill
asthma
close
one
age
group
long
appreci
certain
viral
infect
infanc
exampl
caus
respiratori
syncyti
viru
rsv
caus
inflamm
obstruct
small
airway
bronchiol
lead
cough
wheez
also
propos
infant
contract
rsv
bronchiol
increas
risk
develop
asthma
later
life
contrast
recent
epidemiolog
studi
indic
viral
infect
increas
risk
asthma
fact
may
actual
reduc
risk
develop
allerg
diseas
asthma
older
children
adult
establish
asthma
common
cold
rel
mild
ill
peopl
caus
sever
pulmonari
problem
fact
exacerb
asthma
children
half
episod
adult
caus
viral
infect
attribut
rhinovirus
articl
consid
relationship
viral
infect
virusinduc
inflamm
develop
activ
asthma
pathogenesi
asthma
review
current
concept
relationship
viral
infect
wheez
ill
asthma
virus
protect
asthma
viral
infect
might
actual
protect
develop
allergi
asthma
controversi
idea
term
hygien
hypothesi
first
suggest
david
strachan
note
risk
develop
allergi
asthma
invers
relat
number
children
famili
result
replic
sever
subsequ
studi
find
led
specul
infecti
diseas
like
transmit
larg
famili
could
modul
develop
immun
system
way
reduc
chanc
develop
allergi
hypothesi
impli
immun
system
skew
toward
h
respons
pattern
birth
accord
theori
viral
infect
would
provid
stimulu
develop
andor
activ
h
immun
respons
result
repetit
stimul
would
chang
polar
h
system
away
h
overexpress
thu
reduc
risk
develop
allergi
fig
earli
report
suggest
contract
singl
infecti
diseas
review
data
relat
posit
neg
influenc
viral
infect
develop
asthma
close
associ
rsv
infect
wheez
syndrom
infant
although
nearli
infant
infect
rsv
first
year
life
subset
infant
develop
wheez
ill
risk
factor
includ
reduc
pulmonari
function
genet
factor
involv
long
recogn
children
develop
wheez
rsv
infect
increas
risk
recurr
wheez
possibl
asthma
interest
childhood
asthma
hospit
due
rsv
infect
increas
preval
past
two
decad
risk
factor
develop
asthma
bronchiol
infanc
relat
sign
indic
allergi
atop
dermat
food
allergi
allerg
rhiniti
furthermor
evid
certain
pattern
immun
respons
infect
includ
eosinophil
inflamm
airway
secret
reduc
product
peripher
blood
mononuclear
cell
pbmc
ex
vivo
increas
ex
vivo
pbmc
secret
convalesc
associ
increas
risk
recurr
wheez
possibl
asthma
anim
model
infect
relat
paramyxoviru
episod
lower
airway
obstruct
sendai
viru
infect
relat
reduc
product
like
addit
immunolog
risk
factor
lower
airway
effect
respiratori
viru
infect
human
identifi
although
lower
airway
infect
rsv
seem
increas
risk
recurr
wheez
childhood
effect
disappear
age
year
indic
increas
import
risk
factor
asthma
later
childhood
key
understand
relationship
viral
infect
infanc
allergi
associ
immun
abnorm
asthma
determin
tempor
sequenc
event
interplay
exist
genesuscept
factor
introduct
viral
infect
fig
sever
viral
infect
infanc
affect
develop
immun
system
modifi
subsequ
risk
allergi
asthma
preexist
abnorm
lung
immun
respons
caus
sever
respiratori
manifest
viral
asthma
complex
interact
process
involv
mani
cell
type
mediat
targetorgan
respons
furthermor
process
involv
progress
acut
event
allergeninduc
activ
mast
cell
releas
proinflammatori
cytokin
mediat
lead
acut
bronchoconstrict
airway
obstruct
chronic
inflamm
b
character
activ
helper
h
cell
macrophag
recruit
degranul
eosinophil
chang
airway
caus
airflow
obstruct
also
increas
airway
respons
final
subject
progress
inflammatori
chang
toward
airway
remodel
c
remodel
chang
lead
perman
alter
airway
architectur
obstruct
event
irrevers
ige
immunoglobulin
e
interleukin
h
helper
cell
tumour
necrosi
factor
wwwnaturecomreviewsimmunol
p
e
r
p
e
c
v
e
begin
address
question
studi
perform
use
techniqu
bronchoscopi
experiment
viral
inocul
determin
proinflammatori
effect
viral
infect
potenti
interact
viral
infect
exist
airway
inflamm
asthma
investig
shown
infect
rhinoviru
enhanc
immedi
histamin
releas
latephas
eosinophil
recruit
airway
respons
allergen
challeng
addit
individu
respiratori
allergi
may
develop
greater
chang
airway
respons
experiment
inocul
rhinoviru
interact
allergi
effect
common
cold
infect
lower
airway
observ
clinic
studi
involv
infect
occur
natur
studi
risk
factor
develop
acut
wheez
episod
ascertain
children
present
emerg
depart
individu
risk
factor
develop
wheez
includ
detect
respiratori
viru
commonli
rhinovirus
posit
allergenspecif
immunoglobulin
e
detect
radioallergosorb
test
rast
either
eosinophilia
evid
eosinophil
degranul
nasal
secret
remark
presenc
viru
nasal
secret
indic
allergi
eosinophil
inflamm
posit
rast
test
synergist
increas
odd
ratio
wheez
tabl
consid
togeth
find
studi
experiment
infect
observ
provid
convinc
evid
peopl
either
respiratori
allergi
eosinophil
airway
inflamm
increas
risk
lower
airway
effect
viral
infect
epitheli
cell
focal
point
pathogenesi
viral
respiratori
infect
serv
host
cell
viral
replic
also
initi
innat
immun
respons
fig
damag
epitheli
cell
disturb
airway
physiolog
sever
differ
pathway
exampl
epitheli
oedema
shed
togeth
mucu
product
caus
airway
obstruct
wheez
immun
respons
viru
includ
cell
recruit
activ
secret
proinflammatori
cytokin
mediat
exampl
leukotrien
kinin
prostenoid
also
contribut
pathogenesi
respiratori
infect
virus
rhinovirus
infect
rel
cell
airway
may
primari
mechan
caus
airway
symptom
lower
airway
dysfunct
cold
viru
produc
sever
wheez
fact
hospit
rate
asthma
commun
parallel
preval
common
cold
addit
rhinovirus
sever
viral
respiratori
infect
exampl
season
infect
influenza
coronaviru
rsv
also
provok
acut
asthma
understand
respiratori
virus
rsv
influenza
viru
affect
lower
airway
physiolog
reason
straightforward
organ
infect
injur
lower
airway
tissu
rhinoviru
tradit
consid
upper
airway
pathogen
earli
studi
indic
replic
better
bodi
temperatur
injuri
effect
airway
tissu
limit
howev
whether
induc
acut
asthma
infect
lower
airway
tissu
controversi
direct
measur
howev
shown
temperatur
proxim
lower
airway
conduc
rhinoviru
replic
exceed
peripheri
lung
moreov
rhinoviru
seem
replic
equal
well
cultur
epitheli
cell
deriv
either
upper
lower
airway
epithelium
detect
lower
airway
cell
secret
experiment
inocul
final
inocul
healthi
volunt
rhinoviru
produc
lower
airway
inflammatori
chang
includ
increas
neutrophil
lymphocyt
intercellular
adhes
molecul
addit
rhinoviru
infect
found
caus
small
increas
lower
airway
eosinophil
studi
remain
area
investig
includ
determin
much
viru
present
lower
airway
establish
whether
viral
replic
lower
airway
suffici
stimulu
provok
exacerb
asthma
measl
protect
allergi
asthma
confirm
howev
hygien
hypothesi
support
studi
show
invers
relationship
attend
day
care
centr
exposur
viral
infect
quit
high
subsequ
rate
allergi
asthma
develop
howev
type
infect
import
also
rout
exposur
foodborn
enter
infect
may
greater
effect
allergi
respiratori
infect
final
may
infect
per
se
import
rather
exposur
microb
microbi
product
environ
concept
support
find
exposur
farm
environ
earli
childhood
andor
exposur
higher
level
lipopolysaccharid
lp
associ
reduc
rate
allergi
asthma
develop
collect
find
indic
repeat
exposur
common
infecti
diseas
prolong
exposur
microbi
product
may
protect
develop
allergi
asthma
concept
confirm
determin
relev
mechan
involv
could
lead
entir
new
approach
prevent
common
problem
clinic
studi
conduct
children
adult
asthma
provid
conclus
evid
infect
caus
respiratori
virus
import
precipit
acut
episod
airway
obstruct
wheez
recent
studi
use
revers
transcript
polymeras
chain
reaction
rtpcr
base
diagnost
assay
rhinoviru
emerg
import
caus
acut
episod
infect
common
potent
stimulu
antivir
innat
immun
respons
dsrna
activ
intracellular
signal
protein
dsrnadepend
protein
kinas
pkr
synthas
activ
pkr
link
nuclear
factor
activ
gener
proinflammatori
antivir
cytokin
moreov
dsrna
activ
pkr
induc
antivir
activ
gener
nitric
oxid
inhibit
cellular
translat
activ
rnase
l
turn
mani
virus
evolv
mechan
inhibit
pathway
increas
probabl
viral
replic
hostcel
recognit
dsrna
seem
import
pathway
initi
multipl
proinflammatori
antivir
pathway
within
cell
whether
innat
antivir
respons
viral
infect
impair
asthma
clearli
interest
howev
yet
determin
follow
initi
viral
replic
epitheli
cell
larg
amount
viru
releas
airway
secret
presum
surround
lung
tissu
point
like
mononuclear
cell
activ
high
titr
viru
secret
proinflammatori
cytokin
tumour
necrosi
factor
cytokin
turn
activ
cell
airway
environ
also
potent
induc
adhes
molecul
express
togeth
chemokin
gener
epitheli
cell
respons
provid
potent
stimulu
recruit
inflammatori
cell
consist
princip
neutrophil
cell
like
product
neutrophil
activ
contribut
obstruct
airway
caus
lower
airway
symptom
concept
support
studi
show
increas
neutrophil
lower
airway
infant
recurr
wheez
clinic
studi
quantiti
neutrophil
neutrophil
activ
product
myeloperoxidas
close
correl
sever
respiratori
symptom
evid
activ
neutrophil
releas
potent
secretagogu
elastas
upregul
mucu
secret
particular
interest
although
viral
infect
gener
caus
mark
increas
airway
eosinophil
chang
eosinophil
cation
protein
releas
activ
eosinophil
neutrophil
correl
disturb
airway
physiolog
find
indic
neutrophil
eosinophil
activ
product
contribut
airway
obstruct
virusinduc
wheez
exacerb
asthma
virusinduc
cytokin
product
inflammatori
cell
activ
like
instrument
develop
neurogen
inflammatori
respons
combin
factor
may
increas
bronchoconstrict
respons
allergen
irrit
viral
replic
affect
cellsurfac
receptor
result
initi
immun
respons
exampl
recent
shown
monocyt
macrophag
cytokin
respons
rsv
fusion
f
protein
mediat
tolllik
receptor
mice
prolong
viral
shed
find
rais
possibl
tlr
famili
receptor
previous
associ
innat
immun
respons
bacteria
also
particip
antivir
respons
contrast
bind
ultravioletinactiv
viru
receptor
rhinovirus
rel
weak
epitheli
cell
stimulu
addit
effect
surfac
receptor
virusinduc
oxid
stress
may
import
stimulu
product
chemokin
replic
singlestrand
rna
virus
rhinovirus
rsv
influenza
viru
lead
product
doublestrand
rna
dsrna
figur
hygien
hypothesi
accord
theori
immun
system
birth
immatur
skew
toward
helper
h
cytokin
product
certain
stimuli
infect
helminth
virus
contract
sibl
peer
day
care
centr
help
immunolog
develop
toward
healthi
balanc
h
h
cytokin
respons
absenc
stimuli
children
contact
children
live
rel
steril
urban
environ
immatur
h
pattern
cytokin
product
persist
lead
increas
risk
asthma
atop
diseas
lp
lipopolysaccharid
wwwnaturecomreviewsimmunol
p
e
r
p
e
c
v
e
hypothesi
indic
exposur
microbi
product
infect
may
greatest
effect
immun
system
develop
protect
allergi
asthma
current
understand
pathogenesi
virusinduc
wheez
asthma
indic
sever
opportun
develop
new
treatment
strategi
first
possibl
either
prevent
viral
infect
use
antivir
medicin
treat
infect
onset
ill
obvious
vaccin
influenza
proven
costeffect
albeit
underus
rsv
prime
target
vaccin
develop
unintend
effect
disturb
immun
system
develop
promot
allergi
asthma
unlik
compel
data
support
hygien
lymphocyt
recruit
upper
lower
airway
earli
stage
viral
respiratori
infect
innat
adapt
immun
respons
may
limit
extent
infect
clear
virusinfect
epitheli
cell
consist
report
sever
viral
respiratori
infect
immunocompromis
patient
anim
model
respiratori
viral
infect
cellular
immun
respons
pattern
cytokin
product
clearli
relat
outcom
respiratori
infect
concept
test
rhinoviru
infect
human
respons
peripher
blood
mononuclear
cell
viru
vitro
assess
group
volunt
inocul
rhinoviru
volunt
strong
respons
viru
shed
less
viru
peak
cold
moreov
evalu
cytokin
pattern
mrna
ratio
sputum
acut
ill
reveal
volunt
stronger
h
respons
tend
reduc
symptom
score
rapid
viral
clearanc
similarli
natur
acquir
influenza
infect
high
concentr
nasal
secret
time
diagnosi
associ
greater
reduct
viral
shed
follow
day
collect
find
indic
virusinduc
cellular
immun
respons
product
particular
may
influenc
clinic
virolog
outcom
respiratori
viral
infect
viral
infect
major
caus
wheez
exacerb
asthma
age
group
unfortun
current
treatment
option
effect
impract
due
high
cost
signific
sideeffect
close
epidemiolog
relationship
viral
infect
wheez
indic
effect
therapeut
strategi
either
prevent
certain
viral
infect
moder
sever
infect
could
major
influenc
prevent
manag
asthma
children
healthi
infanc
howev
odd
ratio
wheez
calcul
separ
three
risk
factor
relat
allerg
inflamm
combin
risk
factor
togeth
rv
infect
detect
rv
rna
reversetranscript
pcr
risk
factor
evalu
rast
test
common
respiratori
allergen
increas
nasal
eosinophil
count
elev
eosinophil
cation
protein
indic
eosinophil
activ
abbrevi
rast
radioallergosorb
test
rv
retroviru
consider
morbid
mortal
associ
rsv
infect
addit
activ
vaccin
passiv
infus
neutral
monoclon
antibodi
rsv
palivizumab
use
prevent
sever
infect
highrisk
infant
although
costli
therapi
practic
gener
use
conceptu
antivir
agent
could
use
treat
viral
infect
earli
cours
ill
prevent
wheez
pulmonari
complic
problem
approach
viral
respiratori
infect
recogn
much
viral
replic
alreadi
occur
consequ
like
limit
potenti
antivir
agent
affect
cours
ill
thu
neuramidas
inhibitor
potent
antivir
activ
vitro
modest
effect
clinic
influenza
effect
use
earli
cours
ill
neuramidas
inhibitor
effect
given
prophylact
shown
prevent
clinic
appar
case
flu
although
approach
advantag
less
costli
altern
immun
prevent
influenza
vaccin
rhinovirus
feasibl
due
larg
number
serotyp
therefor
prophylact
use
antivir
medic
may
reason
strategi
prevent
asthma
exacerb
affect
individu
sever
antivir
agent
develop
treatment
rhinoviru
infect
includ
solubl
capsidbind
agent
either
hinder
rhinoviru
bind
cellular
receptor
inhibit
uncoat
viru
releas
rna
insid
cell
addit
inhibitor
rhinoviru
proteas
reduc
rhinoviru
replic
vitro
compound
test
clinic
trial
shown
antivir
activ
anoth
potenti
therapeut
approach
respiratori
viral
infect
asthma
inhibit
proinflammatori
immun
respons
induc
viru
either
target
specif
signal
pathway
proinflammatori
cytokin
mediat
fact
approach
proven
effect
system
administr
glucocorticoid
first
sign
cold
reduc
acut
airway
obstruct
risk
hospit
acut
exacerb
asthma
note
oral
corticosteroid
ineffect
reduc
wheez
caus
rsv
infect
infant
indic
differ
pathogenesi
two
clinic
syndrom
new
find
regard
immunopathogenesi
viral
respiratori
ill
indic
may
possibl
inhibit
virusinduc
immun
respons
proinflammatori
without
block
antivir
effector
ifn
secret
tcellmedi
respons
need
clear
viru
infect
although
evid
causeandeffect
relationship
specif
cell
mediat
viral
respiratori
ill
present
circumstanti
viral
induct
neutrophil
inflamm
close
associ
clinic
symptom
make
pathway
promis
therapeut
target
absenc
valid
anim
model
rhinovirusinduc
exacerb
asthma
test
hypothesi
await
develop
inhibitor
proinflammatori
pathway
suitabl
human
clinic
trial
asthma
clearli
complex
collect
clinic
phenotyp
common
propens
develop
acut
episod
airway
obstruct
wheez
concept
support
genet
studi
provid
compel
evid
mani
gene
may
involv
confer
increas
risk
asthma
given
clinic
genet
divers
disord
like
viral
respiratori
infect
infanc
later
life
could
produc
differ
effect
depend
genet
environment
factor
led
diseas
current
futur
studi
identifi
function
signific
genebyenviron
interact
like
yield
new
insight
relationship
viral
infect
wheez
asthma
